Serologic Responses of West Nile Virus Seronegative Mature Horses to West Nile Virus Vaccines

被引:6
作者
Cortese, Victor [1 ]
Hankins, Kevin [2 ]
Holland, Rob [3 ]
Syvrud, Kevin [4 ]
机构
[1] Zoetis Anim Hlth, Simpsonville, KY USA
[2] Zoetis Anim Hlth, Kansas City, KS USA
[3] Zoetis Anim Hlth, Lexington, KY USA
[4] Summit Res Ctr, Helena, MT USA
关键词
Vaccination; Antibodies; West Nile virus; HAEMOLYTICA; IMMUNITY;
D O I
10.1016/j.jevs.2013.04.010
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
A 42-day study was conducted to assess the impact of three West Nile virus vaccines given either as separate injections or incorporated with their counterpart equine encephalitis and tetanus vaccines on serological responses under field use conditions. Two hundred forty mature, West Nile virus seronegative (<4) horses were followed serologically pre- and postprimary and secondary vaccination with six different vaccination programs, all including West Nile virus antigens. Forty horses were unvaccinated sentinel horses. All vaccines stimulated both a primary and secondary (booster) response to vaccination that was significantly higher than that of seronegative controls. However, inclusion of West Nile virus with equine encephalitis viruses and tetanus toxoid in vaccines had a significant detrimental impact on West Nile virus serum neutralization antibody production to both the primary and secondary vaccinations. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1101 / 1105
页数:5
相关论文
共 19 条
  • [1] Structures of immature flavivirus particles
    Zhang, Y
    Corver, J
    Chipman, PR
    Zhang, W
    Pletnev, SV
    Sedlak, D
    Baker, TS
    Strauss, JH
    Kuhn, RJ
    Rossmann, MG
    [J]. EMBO JOURNAL, 2003, 22 (11) : 2604 - 2613
  • [2] Serologic response to Mannheimia haemolytica in calves concurrently inoculated with inactivated or modified-live preparations of M haemolytica and viral combination vaccines containing modified-live bovine herpesvirus type 1
    Cortese, Victor S.
    Seeger, Jon T.
    Stokka, Gerald S.
    Hunsaker, Breck D.
    Lardy, Gregory P.
    Weigel, Daniel J.
    Brumbaugh, Gordon W.
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2011, 72 (11) : 1541 - 1549
  • [3] Crom RL, 2001, UPDATE CURRENT STATU
  • [4] Immunologic responses to West Nile virus in vaccinated and clinically affected horses'
    Davidson, AH
    Traub-Dargatz, JL
    Rodeheaver, RM
    Ostlund, EN
    Pedersen, DD
    Moorhead, RG
    Stricklin, JB
    Dewell, RD
    Roach, SD
    Long, RE
    Albers, SJ
    Callan, RJ
    Salman, MD
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2005, 226 (02): : 240 - 245
  • [5] Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis
    Desprès, P
    Combredet, C
    Frenkiel, MP
    Lorin, C
    Brahic, M
    Tangy, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) : 207 - 214
  • [6] Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine
    Eskola, J
    Olander, RM
    Hovi, T
    Litmanen, L
    Peltola, S
    Kayhty, H
    [J]. LANCET, 1996, 348 (9043) : 1688 - 1692
  • [7] HARLAND RJ, 1992, CAN VET J, V33, P734
  • [8] A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus
    Iglesias, Maria Candela
    Frenkiel, Marie-Pascale
    Mollier, Karine
    Souque, Philippe
    Despres, Philippe
    Charneau, Pierre
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (03) : 265 - 274
  • [9] Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival
    Julander, JG
    Winger, QA
    Olsen, AL
    Day, CW
    Sidwell, RW
    Morrey, JD
    [J]. ANTIVIRAL RESEARCH, 2005, 65 (02) : 79 - 85
  • [10] A recombinant envelope protein vaccine against West Nile virus
    Ledizet, M
    Kar, K
    Foellmer, HG
    Tian, W
    Bushmich, SL
    Anderson, JF
    Fikrig, E
    Koski, RA
    [J]. VACCINE, 2005, 23 (30) : 3915 - 3924